These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6105394)

  • 1. Renal clearance of pentavalent antimony (sodium stibogluconate).
    Rees PH; Keating MI; Kager PA; Hockmeyer WT
    Lancet; 1980 Aug; 2(8188):226-9. PubMed ID: 6105394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study.
    Thakur CP; Kumar M; Kumar P; Mishra BN; Pandey AK
    Br Med J (Clin Res Ed); 1988 Jun; 296(6636):1557-61. PubMed ID: 2840172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of Kenyan kala-azar to treatment with sodium stibogluconate.
    Rees PH; Kager PA; Wellde BT; Hockmeyer WT
    Am J Trop Med Hyg; 1984 May; 33(3):357-61. PubMed ID: 6329010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two dosage schedules of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya.
    Anabwani GM; Ngira JA; Dimiti G; Bryceson AD
    Lancet; 1983 Jan; 1(8318):210-3. PubMed ID: 6130246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of regimens of treatment with sodium stibogluconate in kala-azar.
    Thakur CP; Kumar M; Singh SK; Sharma D; Prasad US; Singh RS; Dhawan PS; Achari V
    Br Med J (Clin Res Ed); 1984 Mar; 288(6421):895-7. PubMed ID: 6322906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on the effect of verapamil with sodium stibogluconate in kala azar.
    Thakur CP; Kumar M
    Trop Geogr Med; 1992 Jan; 44(1-2):15-8. PubMed ID: 1323160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged sodium stibogluconate therapy in Indian kala-azar.
    Jha TK; Sharma VK
    J Assoc Physicians India; 1986 Jul; 34(7):469-71. PubMed ID: 3019993
    [No Abstract]   [Full Text] [Related]  

  • 8. Kala-azar: unresponsiveness to prolonged sodium stibogluconate therapy.
    Bhattacharya D; Majhi TK; Dutta RK
    J Assoc Physicians India; 1987 Jul; 35(7):543. PubMed ID: 2828305
    [No Abstract]   [Full Text] [Related]  

  • 9. Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine.
    Bryceson AD; Chulay JD; Mugambi M; Were JB; Gachihi G; Chunge CN; Muigai R; Bhatt SM; Ho M; Spencer HC
    Trans R Soc Trop Med Hyg; 1985; 79(5):705-14. PubMed ID: 3006295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate.
    Baillie AJ; Coombs GH; Dolan TF; Laurie J
    J Pharm Pharmacol; 1986 Jul; 38(7):502-5. PubMed ID: 2875149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral leishmaniasis in the BALB/c mouse: antimony tissue disposition and parasite suppression after the administration of free stibogluconate.
    Collins M; Carter KC; Baillie AJ
    Ann Trop Med Parasitol; 1992 Feb; 86(1):35-40. PubMed ID: 1319700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar.
    Mishra M; Biswas UK; Jha AM; Khan AB
    Lancet; 1994 Dec; 344(8937):1599-600. PubMed ID: 7983993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
    Maheshwari A; Seth A; Kaur S; Aneja S; Rath B; Basu S; Patel R; Dutta AK
    Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renal impairment on the pharmacokinetics of antimony in hamsters.
    Zaghloul IY; Al-Jasser M
    Ann Trop Med Parasitol; 2004 Dec; 98(8):793-800. PubMed ID: 15667712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmful effect of high stibogluconate treatment of kala-azar in India.
    Thakur CP
    Trans R Soc Trop Med Hyg; 1986; 80(4):672-3. PubMed ID: 3027929
    [No Abstract]   [Full Text] [Related]  

  • 16. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate).
    Chulay JD; Spencer HC; Mugambi M
    Am J Trop Med Hyg; 1985 Jul; 34(4):702-9. PubMed ID: 2992303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
    Bourée P; Anciaux ML; Taugourdeau P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimony content of the thyroid of man and animals undergoing visceral leishmaniasis treatment with the organic compound of antimony, stibogluconate sodium].
    Fuzaĭlov IuM
    Med Parazitol (Mosk); 1982; 51(1):62-5. PubMed ID: 6278277
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate.
    Chunge CN; Owate J; Pamba HO; Donno L
    Trans R Soc Trop Med Hyg; 1990; 84(2):221-5. PubMed ID: 2167522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial.
    Thakur CP; Bhowmick S; Dolfi L; Olliaro P
    Trans R Soc Trop Med Hyg; 1995; 89(2):219-23. PubMed ID: 7778155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.